259 related articles for article (PubMed ID: 37015822)
1. Predictive Value of Serum Neurofilament Light Chain Levels in Anti-NMDA Receptor Encephalitis.
Brenner J; Mariotto S; Bastiaansen AEM; Paunovic M; Ferrari S; Alberti D; de Bruijn MAAM; Crijnen YS; Schreurs MWJ; Neuteboom RF; Damoiseaux JGMC; de Vries JM; Titulaer MJ
Neurology; 2023 May; 100(21):e2204-e2213. PubMed ID: 37015822
[TBL] [Abstract][Full Text] [Related]
2. CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study.
Nissen MS; Ryding M; Nilsson AC; Madsen JS; Olsen DA; Halekoh U; Lydolph M; Illes Z; Blaabjerg M
Front Immunol; 2021; 12():719432. PubMed ID: 34975832
[TBL] [Abstract][Full Text] [Related]
3. Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis.
Mariotto S; Gajofatto A; Zuliani L; Zoccarato M; Gastaldi M; Franciotta D; Cantalupo G; Piardi F; Polo A; Alberti D; Sartori S; Zanusso G; Agrò L; Demurtas R; Sechi G; Sechi E; Monaco S; Ferrari S
J Neurol; 2019 Jul; 266(7):1643-1648. PubMed ID: 30944980
[TBL] [Abstract][Full Text] [Related]
4. Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis.
Guasp M; Martín-Aguilar L; Sabater L; Bioque M; Armangué T; Martínez-Hernández E; Landa J; Maudes E; Borràs R; Muñoz-Lopetegi A; Saiz A; Castro-Fornieles J; Graus F; Parellada E; Querol L; Dalmau J
Neurology; 2022 Apr; 98(14):e1489-e1498. PubMed ID: 35145006
[TBL] [Abstract][Full Text] [Related]
5. Serum NfL associated with anti-NMDA receptor encephalitis.
Ma X; Lu Y; Peng F; Wang Y; Sun X; Luo W; Shen S; Liu Z; Kermode AG; Qiu W; Shu Y
Neurol Sci; 2022 Jun; 43(6):3893-3899. PubMed ID: 35041115
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal measurement of cerebrospinal fluid neurofilament light in anti-N-methyl-D-aspartate receptor encephalitis.
Macher S; Zrzavy T; Höftberger R; Altmann P; Pataraia E; Zimprich F; Berger T; Rommer P
Eur J Neurol; 2021 Apr; 28(4):1401-1405. PubMed ID: 33145945
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid light and heavy neurofilament level increased in anti-N-methyl-d-aspartate receptor encephalitis.
Li J; Gu Y; An H; Zhou Z; Zheng D; Wang Z; Wen Z; Shen HY; Wang Q; Wang H
Brain Behav; 2019 Aug; 9(8):e01354. PubMed ID: 31313506
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid biomarkers of brain injury, inflammation and synaptic autoimmunity predict long-term neurocognitive outcome in herpes simplex encephalitis.
Westman G; Aurelius E; Ahlm C; Blennow K; Eriksson K; Lind L; Schliamser S; Sund F; Zetterberg H; Studahl M
Clin Microbiol Infect; 2021 Aug; 27(8):1131-1136. PubMed ID: 32979577
[TBL] [Abstract][Full Text] [Related]
9. Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies.
Mariotto S; Farinazzo A; Magliozzi R; Alberti D; Monaco S; Ferrari S
J Peripher Nerv Syst; 2018 Sep; 23(3):174-177. PubMed ID: 29974556
[TBL] [Abstract][Full Text] [Related]
10. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
[TBL] [Abstract][Full Text] [Related]
11. Prospective Quantification of CSF Biomarkers in Antibody-Mediated Encephalitis.
Day GS; Yarbrough MY; Körtvelyessy P; Prüss H; Bucelli RC; Fritzler MJ; Mason W; Tang-Wai DF; Steriade C; Hébert J; Henson RL; Herries EM; Ladenson JH; Lopez-Chiriboga AS; Graff-Radford NR; Morris JC; Fagan A
Neurology; 2021 May; 96(20):e2546-e2557. PubMed ID: 33795390
[TBL] [Abstract][Full Text] [Related]
12. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.
Titulaer MJ; McCracken L; Gabilondo I; Armangué T; Glaser C; Iizuka T; Honig LS; Benseler SM; Kawachi I; Martinez-Hernandez E; Aguilar E; Gresa-Arribas N; Ryan-Florance N; Torrents A; Saiz A; Rosenfeld MR; Balice-Gordon R; Graus F; Dalmau J
Lancet Neurol; 2013 Feb; 12(2):157-65. PubMed ID: 23290630
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H
Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123
[TBL] [Abstract][Full Text] [Related]
14. Serum neurofilament light: A biomarker of neuroaxonal injury after ischemic stroke.
Tiedt S; Duering M; Barro C; Kaya AG; Boeck J; Bode FJ; Klein M; Dorn F; Gesierich B; Kellert L; Ertl-Wagner B; Goertler MW; Petzold GC; Kuhle J; Wollenweber FA; Peters N; Dichgans M
Neurology; 2018 Oct; 91(14):e1338-e1347. PubMed ID: 30217937
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal model.
Yeo T; Bayuangga H; Augusto-Oliveira M; Sealey M; Claridge TDW; Tanner R; Leppert D; Palace J; Kuhle J; Probert F; Anthony DC
J Neuroinflammation; 2022 Oct; 19(1):252. PubMed ID: 36210459
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis.
Ciano-Petersen NL; Robert M; Muñiz-Castrillo S; Wucher V; Klich A; Vogrig A; Villagrán García M; Farina A; Goncalves D; Picard G; Rogemond V; Joubert B; Oliver-Martos B; Serrano-Castro PJ; Maucort-Boulch D; Honnorat J
Neurol Neuroimmunol Neuroinflamm; 2023 Jul; 10(4):. PubMed ID: 37147137
[TBL] [Abstract][Full Text] [Related]
17. Association of serum Gasdermin D with anti-N-methyl-D-aspartate receptor encephalitis.
Ma X; Chen C; Lu Y; Fang L; Cao B; Hu X; Qiu W; Shu Y
J Neurochem; 2021 Dec; 159(5):923-930. PubMed ID: 34418095
[TBL] [Abstract][Full Text] [Related]
18. Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3.
Li QF; Dong Y; Yang L; Xie JJ; Ma Y; Du YC; Cheng HL; Ni W; Wu ZY
Mol Neurodegener; 2019 Nov; 14(1):39. PubMed ID: 31684998
[TBL] [Abstract][Full Text] [Related]
19. Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus.
Tyrberg T; Nilsson S; Blennow K; Zetterberg H; Grahn A
J Neurovirol; 2020 Oct; 26(5):719-726. PubMed ID: 32816287
[TBL] [Abstract][Full Text] [Related]
20. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.
Gresa-Arribas N; Titulaer MJ; Torrents A; Aguilar E; McCracken L; Leypoldt F; Gleichman AJ; Balice-Gordon R; Rosenfeld MR; Lynch D; Graus F; Dalmau J
Lancet Neurol; 2014 Feb; 13(2):167-77. PubMed ID: 24360484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]